《滬深兩市》上證全日近平收企3,200點之上 創板偏好 醫藥股顯著回吐
內地昨日(5日)新增本土確診病例4,988例,新增本土無症狀感染者22,859例。人行今日(6日)開展20億元人民幣(下同)7天期逆回購操作,單日淨回籠780億元。人民幣兌美元中間價今再上調638點。A股三大指數低開後個別發展,上證企穩3,200點水平之上,創板反覆先升後回順。
上證全日平收報3,212點,成交額4,352.5億元。深成指收報11,398點,升75點或0.7%,成交額5,630億元。創業板指收報2,393點,升16點或0.7%,成交額1,723億元。
中資金融股工行(601398.SH)及建行(601939.SH)分別升0.2%及0.4%。
憧憬防疫措施進一步放寬,白酒消費類股有好表現,貴州茅台(600519.SH)升1.4%。酒鬼酒(000799.SZ)、五糧液(000858.SZ)及山西汾酒(600809.SH)升3.6%-7.3%。
醫藥股顯著回吐,一心堂(002727.SZ)及特一藥業(002728.SZ)跌停。
半導體股走強,芯源微(688037.SH)揚7.3%。大港股份(002077.SZ)漲停。
比亞迪(002594.SZ)及寧德時代(300750.SZ)分別升1.6%及2%。福田汽車(600166.SH)擬與寧德時代共同出資成立福田時代新能源科技有限公司,開展新能源電池經營性租賃業務,股價揚8.4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.